GlassScriptPhysician profile
Jerry Yuan
NPI 1104895762
$4,947.43
in general payments reported to CMS, 2019-2025
39 companies · $630 in 2025
The $630 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $421 · 2021: $937 · 2022: $920 · 2023: $839 · 2024: $606 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,074.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $534.08 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $323.03 | 2019-2024 | Xiaflex, Aveed |
| Srs Medical Systems, INC. | $319.13 | 2019-2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Teleflex LLC | $311.07 | 2021-2024 | Urolift |
| Myovant Sciences INC. | $296.85 | 2021-2022 | |
| Pfizer INC. | $289.85 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $284.15 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $277.50 | 2023-2025 | Orgovyx |
| Astellas Pharma US INC | $265.11 | 2019-2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $221.88 | 2020-2025 | Lynparza |
| Dendreon Pharmaceuticals LLC | $177.73 | 2021-2024 | Provenge |
| Merck Sharp & Dohme LLC | $175.13 | 2022-2023 | Lynparza, Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $139.96 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $126.97 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $97.04 | 2024-2025 | Tlando, Trelstar |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $92.78 | 2020-2022 | |
| Procept Biorobotics Corporation | $91.79 | 2022-2023 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $80.59 | 2025 | Erleada |
| Kowa Pharmaceuticals America, INC. | $76.00 | 2022-2023 | Seglentis |
| Urogen Pharma, INC. | $75.42 | 2023-2025 | Jelmyto |
| Blue Earth Diagnostics | $73.73 | 2021-2023 | |
| Medtronic, INC. | $67.85 | 2024-2025 | Interstim |
| Vertex Pharmaceuticals Incorporated | $66.69 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $65.83 | 2021-2024 | Prolaris |
| Antares Pharma, INC. | $53.48 | 2024-2025 | Xyosted |
| Laborie Medical Technologies Corp. | $51.58 | 2021-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $50.20 | 2021-2025 | Titan |
| Biotissue Holdings INC. | $38.19 | 2023 | |
| Angiodynamics, INC. | $34.73 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $30.61 | 2025 | Bard Urinary Drainage Bag |
| Tolmar, INC. | $26.21 | 2025 | Eligard, Jatenzo |
| Allergan, INC. | $23.39 | 2022 | |
| Urovant Sciences INC | $22.71 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $22.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.61 | 2025 | |
| Olympus America INC. | $14.56 | 2025 | Soltive |
| Travere Therapeutics, INC. | $11.46 | 2020-2021 | |
| 180 Medical, INC. | $11.29 | 2019 | |
| Axonics, INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Yuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.